Nephro Care — 360° view

Nephro Care, a company in the Hospital industry, reported revenue of ₹33 crore and net profit of ₹2.76 crore for the September 2026 quarter.

Nephro Care (NSE: NEPHROCARE-SM) closed at ₹91.95 on 20 Nov 2026. Its market capitalisation is ₹152 crore and it trades at 26.2 times earnings.

Share price
₹91.95 (20 Nov 2026)
Market cap
₹152 Cr (20 Nov 2026)
P/E
26.18 (20 Nov 2026)
Revenue
₹33 Cr (September 2026 quarter)
Net profit
₹3 Cr (September 2026 quarter)
ROCE
7.90% (FY26)
ROE
5.07% (FY26)
Book value
₹37.1 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹107.70 / ₹74.95 (20 Nov 2026)
Sector
Healthcare
Industry
Hospital
Symbol
NSE: NEPHROCARE-SM

Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes in the treatment of kidney- related diseases

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.